IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 103 filers reported holding IMMUNOMEDICS INC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $77,559,000 | +373.6% | 912,140 | +97.4% | 1.13% | +327.2% |
Q2 2020 | $16,378,000 | +13002.4% | 462,140 | +131.1% | 0.26% | +6525.0% |
Q1 2019 | $125,000 | -98.8% | 200,000 | -77.8% | 0.00% | -99.0% |
Q4 2018 | $10,808,000 | +2334.2% | 900,000 | +4118.4% | 0.41% | +3333.3% |
Q3 2018 | $444,000 | -77.1% | 21,335 | -92.9% | 0.01% | -89.2% |
Q1 2017 | $1,941,000 | +11317.6% | 300,060 | +5515.9% | 0.11% | +11000.0% |
Q3 2016 | $17,000 | -96.7% | 5,343 | -97.6% | 0.00% | -97.2% |
Q2 2016 | $514,000 | -85.5% | 221,700 | -84.4% | 0.04% | -88.4% |
Q1 2016 | $3,550,000 | +478.2% | 1,420,000 | +610.0% | 0.31% | +591.1% |
Q4 2015 | $614,000 | -88.4% | 200,000 | -84.6% | 0.04% | -85.8% |
Q2 2015 | $5,278,000 | +101.1% | 1,300,000 | +116.7% | 0.32% | +55.9% |
Q1 2015 | $2,625,000 | +20092.3% | 600,000 | +20930.5% | 0.20% | +10100.0% |
Q4 2013 | $13,000 | -99.9% | 2,853 | -99.8% | 0.00% | -99.5% |
Q3 2013 | $9,146,000 | +127.5% | 1,475,010 | +99.6% | 0.38% | -6.9% |
Q2 2013 | $4,021,000 | – | 739,144 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 3,850,000 | $12,513,000 | 4.70% |
Avoro Capital Advisors LLC | 7,344,177 | $23,869,000 | 4.19% |
NEXTHERA CAPITAL LP | 1,263,276 | $4,106,000 | 2.52% |
Opaleye Management Inc. | 1,200,000 | $3,900,000 | 2.04% |
First Light Asset Management, LLC | 992,867 | $3,227,000 | 1.39% |
DAFNA Capital Management LLC | 566,796 | $1,842,000 | 1.28% |
Ghost Tree Capital, LLC | 2,000,000 | $6,500,000 | 1.05% |
Iguana Healthcare Management, LLC | 600,000 | $1,950,000 | 0.35% |
PURA VIDA INVESTMENTS, LLC | 319,565 | $1,039,000 | 0.32% |
J. Goldman & Co LP | 1,696,699 | $5,514,000 | 0.31% |